ATE432948T1 - Verfahren zur beseitigung von viren und prionen aus immunglobulinzusammensetzungen - Google Patents

Verfahren zur beseitigung von viren und prionen aus immunglobulinzusammensetzungen

Info

Publication number
ATE432948T1
ATE432948T1 AT02252375T AT02252375T ATE432948T1 AT E432948 T1 ATE432948 T1 AT E432948T1 AT 02252375 T AT02252375 T AT 02252375T AT 02252375 T AT02252375 T AT 02252375T AT E432948 T1 ATE432948 T1 AT E432948T1
Authority
AT
Austria
Prior art keywords
prions
viruses
elimination
immunoglobulin
immunoglobulin compositions
Prior art date
Application number
AT02252375T
Other languages
English (en)
Inventor
Holten Robert Van
Original Assignee
Ortho Clinical Diagnostics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23074738&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE432948(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Ortho Clinical Diagnostics Inc filed Critical Ortho Clinical Diagnostics Inc
Application granted granted Critical
Publication of ATE432948T1 publication Critical patent/ATE432948T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/06—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies from serum
    • C07K16/065—Purification, fragmentation
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/34—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against blood group antigens
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/36—Extraction; Separation; Purification by a combination of two or more processes of different types

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Hematology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AT02252375T 2001-04-02 2002-04-02 Verfahren zur beseitigung von viren und prionen aus immunglobulinzusammensetzungen ATE432948T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US28080701P 2001-04-02 2001-04-02

Publications (1)

Publication Number Publication Date
ATE432948T1 true ATE432948T1 (de) 2009-06-15

Family

ID=23074738

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02252375T ATE432948T1 (de) 2001-04-02 2002-04-02 Verfahren zur beseitigung von viren und prionen aus immunglobulinzusammensetzungen

Country Status (7)

Country Link
US (1) US20040110931A1 (de)
EP (1) EP1247818B1 (de)
JP (1) JP4523222B2 (de)
AT (1) ATE432948T1 (de)
AU (1) AU784808B2 (de)
CA (1) CA2379901A1 (de)
DE (1) DE60232477D1 (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE555666T1 (de) * 2002-05-23 2012-05-15 Ortho Clinical Diagnostics Inc Einfang, konzentration und quantifizierung eines abnormalen prionproteins aus biologischen flüssigkeiten mittels tiefenfiltration
EP2261230B1 (de) 2002-09-11 2017-05-10 Chugai Seiyaku Kabushiki Kaisha Verfahren zur Proteinreinigung
WO2004089402A1 (ja) * 2003-04-09 2004-10-21 Juridical Foundation The Chemo-Sero-Therapeutic Research Institute アルブミン製剤の製造方法
WO2006042541A1 (en) * 2004-10-21 2006-04-27 Statens Serum Institut A method comprising nanofiltration to obtain an mbl product safe from infectious agents and the product obtainable by this method
US7741455B2 (en) * 2004-11-09 2010-06-22 Ares Trading Sa Method for purifying FSH
AU2005229674B2 (en) * 2004-11-18 2010-11-04 Kedrion Melville Inc. Low concentration solvent/detergent process of immuneglobulin with pre-treatment
SG155183A1 (en) 2005-08-26 2009-09-30 Ares Trading Sa Process for the preparation of glycosylated interferon beta
US8604175B2 (en) 2005-12-09 2013-12-10 Ares Trading S.A. Method for purifying FSH or a FSH mutant
CA2571800A1 (en) * 2005-12-23 2007-06-23 Canadian Blood Services Nitrophenyls and related compounds and thimerosal for the inhibition of immune related cell or tissue destruction
BR112012005485A2 (pt) 2009-09-10 2016-04-19 Lonza Biologics Plc método e sistema para a purificação de polipeptídeo
EP3119412A1 (de) * 2014-03-21 2017-01-25 Boreal Invest Endgültige nanofiltration von gelösten proteinzusammensetzungen zur entfernung von immunogenen aggregaten
SG10202008789QA (en) * 2014-05-13 2020-10-29 Amgen Inc Process control systems and methods for use with filters and filtration processes
CN106950326B (zh) * 2017-03-10 2018-05-29 武汉大学 一种化学标记结合lc-ms的方法及其在核苷酸分析中的应用
CA3098609A1 (en) * 2018-05-17 2019-11-21 Csl Behring Ag Method and system of protein extraction
WO2021099529A1 (en) * 2019-11-20 2021-05-27 Csl Behring Ag Method for extracting a protein from a precipitate and method for precipitating impurities

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2390074A (en) * 1942-02-09 1945-12-04 Research Corp Protein product and process
US3449314A (en) * 1966-06-03 1969-06-10 Ortho Pharma Corp Preparation of anti-rh globulin from human plasma
US3916026A (en) * 1968-09-19 1975-10-28 Biotest Serum Institut Gmbh Method for the preparation of gamma-globulin suitable for intravenous use
US4021540A (en) * 1975-07-28 1977-05-03 Ortho Diagnostics Inc. Preparation of a hepatitis B immune globulin and use thereof as a prophylactic material
US4859340A (en) * 1976-03-15 1989-08-22 Cuno, Incorporated Filter sheet
DE2624373C2 (de) * 1976-05-31 1983-02-03 Arnold Dr. 8782 Karlstadt Seufert Verfahren zur Herstellung von steril filtriertem Kryopräzipilat mit einer Anreicherung des Faktors VIII
US4590002A (en) * 1984-12-10 1986-05-20 Ortho Diagnostic Systems, Inc. Methods for preparation of highly purified, gamma globulins free of hepatitis-B-virus infectivity
US5173415A (en) * 1986-01-20 1992-12-22 Japan Chemical Research Co., Ltd. Process for removal of viruses from solutions of physiologically active substances
DE3641115A1 (de) * 1986-12-02 1988-06-16 Lentia Gmbh Verfahren zur herstellung eines intravenoes anwendbaren und in fluessiger form stabilen immunglobulins
US5115101A (en) * 1988-06-08 1992-05-19 Miles Inc. Removal of protein A from antibody preparations
FR2639645B1 (fr) * 1988-11-25 1992-05-29 Elf Aquitaine Solutions liquides concentrees de polysaccharides
DE4137996A1 (de) * 1991-11-19 1993-05-27 Behringwerke Ag Verfahren zur herstellung eines virussicheren thrombinkonzentrates
US5858641A (en) * 1996-09-17 1999-01-12 Shanbrom Technologies, Llc Disinfectant dye removal from blood and blood fractions using a porous poly(vinyl alcohol-acetal) copolymer
US6221614B1 (en) * 1997-02-21 2001-04-24 The Regents Of The University Of California Removal of prions from blood, plasma and other liquids
US6096872A (en) * 1997-10-14 2000-08-01 Ortho Diagnostic Systems, Inc. Viral clearance process
FR2772381B1 (fr) * 1997-12-15 2001-06-08 Lab Francais Du Fractionnement Procede de preparation par filtration d'une solution de facteur viii securisee viralement
WO2000043048A1 (en) * 1999-01-19 2000-07-27 Common Services Agency Treating protein-containing liquids
US6166187A (en) * 1999-03-05 2000-12-26 The Regents Of The University Of California Method of concentrating prion proteins in blood samples
US6270672B1 (en) * 1999-08-06 2001-08-07 Baxter Aktiengesellschaft Devices and methods for removing pathogens from biological fluids

Also Published As

Publication number Publication date
EP1247818A2 (de) 2002-10-09
JP4523222B2 (ja) 2010-08-11
JP2003064099A (ja) 2003-03-05
DE60232477D1 (de) 2009-07-16
CA2379901A1 (en) 2002-10-02
US20040110931A1 (en) 2004-06-10
AU784808B2 (en) 2006-06-29
EP1247818A3 (de) 2004-03-03
EP1247818B1 (de) 2009-06-03
AU2931602A (en) 2002-10-03

Similar Documents

Publication Publication Date Title
ATE388162T1 (de) Verfahren zur beseitigung von viren
ATE432948T1 (de) Verfahren zur beseitigung von viren und prionen aus immunglobulinzusammensetzungen
ATE296315T1 (de) Galactosylierte glykoproteine enthaltende zusammensetzungen und verfahren zur deren herstellung
ATE382358T1 (de) Verfahren und zusammensetzungen zum sauerstofftransport mit hoher sauerstoffaffinität
CY1118467T1 (el) Σκευασματα αντισωματων και πρωτεϊνων υψηλης συγκεντρωσης
ATE419009T1 (de) Methoden und zusammensetzungen bestehend aus glykoprotein-glykoformen
MY162525A (en) Process for concentration of antibodies and therapeutic products thereof
ATE325133T1 (de) Verfahren zur herstellung von fibrinogen und fibronectin sowie proteinzusammesetzungen, welche damit herstellbar sind
DE69934269D1 (de) Verfahren zur Reinigung und Isolierung von Viren, aus Pflanzenquellen
DE69432109D1 (de) Synthetische, vielfache tandemwiederholungen des mucinpeptides und seiner derivate und deren verwendung
ATE553125T1 (de) Herstellung eines multimeren proteins durch zellfusionsverfahren
ATE258984T1 (de) Bmp-11 zusammensetzungen
ATE404588T1 (de) Verfahren zur herstellung von chondroitinsulfaten aus k4-polysaccharid und so hergestellte produkte
DE60106469D1 (de) Verfahren zur Herstellung von genetisch veränderten Lymphozyten Vorläuferzellen von Wirbeltieren und deren Gebrauch zur Produktion von heterologen Bindeproteinen
ATE346095T1 (de) Glycoprotein vi - fc fusions protein zur behandlung von gefässerkrankungen
DE60234100D1 (de) Verwendung von "hypoxia inducible factor 2alpha" zur behandlung von "neonatal respiratory distress syndrome"
NO20013918D0 (no) Fremgangsmate for a inaktivere patogener ved anvendelse av bredspektret pulset lys
DE69434221D1 (de) Bindungs domänen von plasmodium vivax und plasmodium falciparum erythrozyten-bindenden proteinen
DE602004032345D1 (de) Reagenzien und verfahren zur bildung von disulfid-bindungen und glykosylierung von proteinen
DE60215649D1 (de) Zusammensetzungen und verfahren zur behandlung von hyperimmunreaktionen im auge
ATE328102T1 (de) Verfahren zur herstellung von proteine
ATE212360T1 (de) Polyethylenglycol-hirudin-konjugate, deren verfahren zur herstellung und verwendung für die heilung von thrombosen
DE59704808D1 (de) Verfahren zur herstellung von kolostralmilchprodukten sowie deren verwendung
ATE372687T1 (de) Verfahren zur verbesserung von proteinprodukten
ATE169821T1 (de) Verwendung boviner kolostralmilch zur herstellung eines arzneimittels für die behandlung von leberfunktionsstörungen

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties